fda glp-1 enforcement news october 2025 Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide Alarming rise in weight loss

Selected Oral Agents for Type 2 Diabetes - Januvia

This move aims to make these treatments more accessible to patients

Which Millennials in Hollywood have gone the GLP-1 route

Observational studies have limitations An editorial published in the journal Eye earlier this summer summarizes the muddy picture that emerges from the handful of imperfect studies looking at this question

Conclusion GLP-1RAs show significant promise as a potential disease-modifying therapy for neurodegenerative and inflammatory eye diseases, acting through both systemic metabolic improvements and direct ocular mechanisms, representing a paradigm shift beyond their metabolic indications.

GLP-1 medications arent always the best first choice for small weight loss